Ecat, Julieta .
HRN: 05-20-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/04/2023
05/10/2023
IV
1.5 G
Q24hours
Cervical Mass Prob Sec Fo Metastatic Colon Cancers/P Explore Lap, Diverting Colostomy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose